Cargando…
HIV Treatment as Prevention: Issues in Economic Evaluation
Meyer-Rath and Over assert in another article in the July 2012 PLoS Medicine Collection, “Investigating the Impact of Treatment on New HIV Infections”, that economic evaluations of antiretroviral therapy (ART) in currently existing programs and in HIV treatment as prevention (TasP) programs should u...
Autores principales: | Bärnighausen, Till, Salomon, Joshua A., Sangrujee, Nalinee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393650/ https://www.ncbi.nlm.nih.gov/pubmed/22802743 http://dx.doi.org/10.1371/journal.pmed.1001263 |
Ejemplares similares
-
HIV Treatment-as-Prevention Research at a Crossroads
por: Bärnighausen, Till, et al.
Publicado: (2014) -
HIV Treatment-As-Prevention Research: Authors’ Reply
por: Bärnighausen, Till, et al.
Publicado: (2015) -
Cost-Effectiveness Analysis of Diagnostic Options for Pneumocystis Pneumonia (PCP)
por: Harris, Julie R., et al.
Publicado: (2011) -
Using interviewer random effects to remove selection bias from HIV prevalence estimates
por: McGovern, Mark E, et al.
Publicado: (2015) -
Assessing the population health impact of market interventions to improve access to antiretroviral treatment
por: Bärnighausen, Till, et al.
Publicado: (2012)